A detailed history of Glen Eagle Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 160 shares of TEVA stock, worth $2,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160
Previous 100 60.0%
Holding current value
$2,974
Previous $1.71 Million 52.14%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $766 - $1,044
60 Added 60.0%
160 $2.6 Million
Q1 2024

Jul 03, 2024

BUY
$10.67 - $14.43 $1,707 - $2,308
160 New
160 $2.26 Million
Q3 2022

Aug 13, 2024

BUY
$6.86 - $11.95 $1,097 - $1,912
160 New
160 $1.29 Million
Q1 2021

Aug 13, 2024

SELL
$10.34 - $12.81 $3,619 - $4,483
-350 Closed
0 $0
Q4 2020

Aug 13, 2024

BUY
$8.61 - $11.04 $1,635 - $2,097
190 Added 118.75%
350 $3.38 Million
Q2 2020

Aug 13, 2024

BUY
$8.12 - $13.12 $1,623 - $2,624
200 Added 133.33%
350 $4.32 Million
Q1 2020

Aug 13, 2024

SELL
$6.69 - $13.45 $66 - $134
-10 Reduced 6.25%
150 $1.35 Million
Q3 2018

Aug 13, 2024

BUY
$21.06 - $25.65 $1,284 - $1,564
61 New
61 $1.31 Million
Q2 2018

Aug 13, 2024

SELL
$16.77 - $24.71 $28,659 - $42,229
-1,709 Closed
0 $0
Q1 2018

Aug 14, 2024

SELL
$16.68 - $22.07 $1,000 - $1,324
-60 Reduced 37.5%
100 $1.71 Million
Q1 2018

Aug 13, 2024

BUY
$16.68 - $22.07 $26,838 - $35,510
1,609 Added 1609.0%
1,709 $1.71 Million
Q4 2017

Aug 13, 2024

SELL
$11.23 - $19.1 $9,545 - $16,235
-850 Reduced 89.47%
100 $1.9 Million
Q3 2017

Aug 13, 2024

BUY
$15.41 - $32.17 $12,173 - $25,414
790 Added 493.75%
950 $16.7 Million
Q2 2017

Aug 12, 2024

SELL
N/A
-5,674 Reduced 83.15%
1,150 $38.2 Million
Q1 2017

Aug 12, 2024

BUY
N/A
515 Added 8.16%
6,824 $223 Million
Q4 2016

Aug 12, 2024

BUY
N/A
6,149
6,309 $229 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.6B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.